Edward Rubin MD PC

04/21/2026

The world of health and wellness is currently witnessing a massive gold rush, and at the center of it are peptides. From blockbuster weight loss medications to the cutting edge of biohacking, these signaling molecules have transformed from a niche area of drug development into a nearly $300 billion global industry. But beneath the staggering growth and surging public interest lies a complicated landscape of regulatory crackdowns, safety concerns, and a confusing legal maze for patients and providers alike.

This exploration dives into the science behind the hype—how these tiny chains of amino acids function as messengers in the body—and unpacks the dramatic regulatory rollercoaster that has defined the last few years. Following the FDA’s 2023 decision to restrict access to popular compounds like BPC-157, a surprising 2026 policy shift is now threatening to turn the industry on its head once again. Get the full story on why access to these compounds is becoming the biggest conversation in modern medicine, and what a potential return to legal compounding could mean for the future of patient care.

*Disclaimer: This content is for informational purposes only and does not constitute medical advice. Always consult with a licensed healthcare provider before making any medical decisions.*

03/18/2026

Imagine spending nearly 40 minutes on the phone with a judge who has zero medical training, all to justify a procedure for a patient they’ve never even heard of. The absurdity of navigating healthcare bureaucracy while simply trying to get someone the care they need is real. It’s wild to think that after four long weeks of waiting for answers, this is what the process actually looks like behind the scenes for healthcare providers. A glimpse into the frustrating reality of modern medicine, where the paperwork often feels more time consuming than the actual patient visit.

03/17/2026

The medical cannabis industry is booming, and millions are turning to it as a potential alternative to traditional pain management. But beyond the hype, what does the actual data say?

While there are promising indicators regarding nerve pain and inflammation, the scientific consensus is more nuanced than many realize. Often, the research relies on small, short-term, or self-reported studies, leaving a significant gap between popular perception and clinical verification.

As we navigate this new frontier, it raises a vital question: are we rushing to adopt treatments before the long-term impacts are fully understood? When it comes to managing health, relying on professional medical guidance rather than anecdotal advice remains the safest route.

Have you explored medical cannabis for pain management? Share your experiences and thoughts on whether the science is keeping up with the trend.

01/27/2026

The sheer absurdity of bureaucratic red tape hitting real patient care is laid bare. Imagine needing a straightforward spinal injection for debilitating pain, only for the insurance company to reject it because the MRI is three years old. Fair enough, order a new one! Then, they deny the *required* new MRI, claiming it isn't medically necessary. It's the ultimate catch-22 for patient treatment. This segment highlights the maddening, circular logic healthcare providers face daily while trying to treat conditions like herniated discs and sciatic nerve pain. What's the most infuriating insurance battle *you've* witnessed or experienced? Share your nightmare denial story below!

01/12/2026

Intradiscal stem cell therapy represents an emerging area of regenerative medicine that researchers are studying for spinal use. This innovative approach aims to support the body's natural healing processes. If you're curious about whether this option might be right for you, consult with a qualified healthcare provider to discuss your individual situation and learn more about the latest developments in regenerative treatments.
Results may vary. This information is for educational purposes only and is not intended to diagnose, treat, cure, or prevent any disease.

11/20/2025

11/05/2025

11/05/2025

Back pain can have many causes — and for some, it starts in the spine itself. The Intracept® Procedure targets a specific source of chronic low back pain through a minimally invasive approach, designed to help improve comfort and restore movement.

Dr. Edward Rubin and his team are proud to offer this innovative option for qualified patients seeking long-term relief. 💪

📍 Learn more about whether the Intracept® Procedure might be right for you by scheduling a consultation.

10/22/2025

Urgent changes are on the horizon that could impact millions of chronic pain sufferers. Dr. Edward Rubin, a board-certified pain specialist, sheds light on the devastating implications of Medicare's proposed elimination of coverage for critical pain management procedures like nerve blocks and radio frequency ablation. Treatments crucial for alleviating migraine, shoulder pain, knee arthritis, and complex regional pain syndrome are at risk of being classified as having very low evidence, potentially denying or stripping coverage for those who rely on them.

This isn't just a shift in policy—it's a critical moment for many facing daily challenges due to chronic pain. Thankfully, there's still time to act. Medicare is welcoming public comments, and your experiences can make a difference! Don’t miss the chance to share your story and advocate for your access to essential pain relief.

Your voice matters in this fight for comprehensive pain management solutions. Let’s stand together and ensure our experiences are heard loud and clear!

https://www.cms.gov/medicare-coverage-database/view/lcd.aspx?lcdid=40266

10/08/2025

New insights into gabapentin are making waves in the medical community. An extensive study analyzed over 26,000 adults suffering from chronic low back pain, revealing concerning trends related to gabapentin prescriptions. Researchers have noted a link between gabapentin use and an increase in memory issues and cognitive changes, especially in younger individuals. While these findings raise important questions, they do not establish a direct cause-and-effect relationship, emphasizing the need for further investigation into the long-term implications. For anyone currently taking gabapentin, it's crucial to have a conversation with your healthcare provider about these findings to tailor a treatment plan that prioritizes your health and well-being. Join the dialogue on the evolving understanding of pain management and its potential risks.